The Department of Anaesthesia and Pain Management has a proud history of conducting quality research. 

About our research

We are committed to evidence-based best practice, continuous quality improvement, research and teaching. We undertake a variety of research including basic research, small research studies of various design conducted by supervised medical students, as well as major international multi-centre clinical trials.

Our focus

Our collaborators

We have close collaborations with:

Malignant hyperthermia (MH)

We are recognised as a world leader in research into novel genetic variants causing MH, with an extensive list of publications.

Dr Robyn Gillies and A/Prof Andrew Bjorksten are founding members of the Malignant Hyperthermia Australia and New Zealand (MHANZ) group and work in the Malignant Hyperthermia Diagnostic Unit (MHDU) at the Royal Melbourne Hospital.

MHDU staff perform clinical and genetic diagnosis and counselling, as well as MH crisis management.

The MHDU coordinates in-vitro contracture testing for MH for patients from Victoria, South Australia, Tasmania, Queensland and Northern Territory. This testing is performed in our departmental laboratory.

Contact the Malignant Hyperthermia Diagnostic Unit for more information.

Current research studies

We participate in clinical trials conducted by the Australian and New Zealand College of Anaesthetists Clinical Trials Network.


A randomised crossover study to compare the user seal check and quantitative fit test between two types of duckbill N95 particulate respirator masks: The Halyard Fluidshield (R) N95 and the BSN Medical ProShield (R) N-95 particulate respirator masks

Williams, DL; Kave, B; Lee, K; Segal, R; Krieser, RB; Mezzavia, PM; Ng, I

(2021), Anaesth. Intensive Care, 112-118

DOI: 10.1177/0310057X20974022

Advocacy for COVID-19 vaccination at perioperative consultations: An opportunity for protection

Douglas, N; Gregorevic, K; Law, M; Thomson, BNJ; Johnson, DF

(2021), ANZ J. Surg., 1964-1965

DOI: 10.1111/ans.17066

Airway management in the adult patient with COVID-19: High flow nasal oxygen or not? A summary of evidence and local expert opinion

Lee, S; Bradley, WPL; Brewster, DJ; Chahal, R; Poon, L; Segal, R; Totonidis, S; Tsang, D; Ng, M

(2021), Anaesth. Intensive Care, 268-274

DOI: 10.1177/0310057X211024691

Contact us
The RMH Parkville
300 Grattan St, Parkville, Victoria
Malignant Hyperthermia Diagnostic Unit
The RMH Parkville
300 Grattan St, Parkville, Victoria
Diabetes and Endocrinology research nurse with patient in Clinical Trials Centre
About clinical trials

We need clinical trials to prove that new treatments are safe and effective for people to use. They are essential to the discovery of new medications and devices, neither of which can be approved for use in Australia without clinical trials.

Last updated 01 November 2022